Physician profile
Andre M Williams
NPI 1942296959
$14,543.96
in general payments reported to CMS, 2019-2025
51 companies · $1,684 in 2025
The $1,684 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,801 · 2020: $699 · 2021: $1,121 · 2022: $4,134 · 2023: $801 · 2024: $1,304 · 2025: $1,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,416 · Travel and Lodging: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,415.96 |
| Travel and Lodging | $373.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,385.10 | 2019-2025 | |
| Organogenesis INC. | $1,374.13 | 2019-2025 | Puraply, Simplimax, Via Matrix |
| Horizon Therapeutics Plc | $949.05 | 2019-2023 | Krystexxa |
| Wright Medical Technology, INC. | $918.25 | 2019-2020 | |
| Treace Medical Concepts, INC. | $736.56 | 2022-2025 | |
| Stryker Corporation | $599.50 | 2019-2025 | Actishield, Augment Injectable, Ortholoc 3di |
| Nevro Corp. | $457.40 | 2019-2024 | Senza |
| Convatec INC. | $423.07 | 2023-2025 | |
| Kerecis Limited | $395.68 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Cook Medical LLC | $338.27 | 2019-2021 | |
| Smith+Nephew, INC. | $281.42 | 2021-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Paratek Pharmaceuticals, INC. | $270.92 | 2022-2025 | Nuzyra |
| Orthofix Medical, INC. | $158.67 | 2020-2025 | Physio-Stim |
| Musculoskeletal Transplant Foundation INC. | $154.72 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $146.83 | 2019 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $145.98 | 2025 | Stimulan |
| Pacira Pharmaceuticals Incorporated | $138.92 | 2019-2020 | |
| Bone Support INC. | $131.60 | 2025 | Ceramentbone Void Filler, Cerament G |
| Aroa Biosurgery Incorporated | $107.82 | 2023-2024 | |
| Rikco International, LLC | $101.00 | 2019 | |
| Coastal Medical Technologies LLC | $98.76 | 2024 | |
| Mvp Orthopedics INC | $93.55 | 2021-2022 | |
| Paragon 28, INC. | $86.65 | 2021-2024 | Portfolio |
| Djo, LLC | $84.08 | 2020-2025 | Cmf |
| Kci USA, INC. | $81.32 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $67.48 | 2019 | |
| Modulated Imaging, INC. | $61.63 | 2021 | |
| Bioventus LLC | $57.24 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Next Science LLC | $51.06 | 2023 | Surgx, Blastx, Xperience |
| Depuy Synthes Sales INC. | $51.02 | 2021-2023 | Motoband, Minibunion |
| Pfizer INC. | $46.56 | 2019-2020 | |
| Ermi LLC | $44.71 | 2020-2021 | |
| Amgen INC. | $44.66 | 2024-2025 | Krystexxa |
| Abbvie INC. | $44.50 | 2021 | |
| Crossroads Extremity Systems, LLC | $39.68 | 2019-2020 | |
| Dynasplint Systems INC. | $38.46 | 2021 | |
| Medtronic, INC. | $31.06 | 2023 | Intellis Adaptivestim |
| Alfasigma USA, INC. | $29.03 | 2020-2021 | |
| Reprise Biomedical, INC. | $27.01 | 2024 | Miro3d |
| Nabriva Therapeutics, Plc | $26.39 | 2021 | |
| Averitas Pharma INC. | $26.01 | 2023 | Qutenza |
| Grt US Holding, INC. | $26.00 | 2022 | |
| Innovation Technologies INC | $24.52 | 2020 | |
| Baxter Healthcare | $23.36 | 2020 | |
| Ossio INC | $22.90 | 2020 | |
| Polarityte, INC. | $21.34 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $19.29 | 2021 | |
| Tenex Health INC. | $19.22 | 2021 | |
| Mannkind Corporation | $15.32 | 2019 | |
| Heraeus Medical, LLC. | $14.94 | 2020 | |
| Melinta Therapeutics, LLC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.